Table 3.
Dependent variables | Independent variables† | Univariate model |
After adjusted for demographic variables‡ |
Multivariate model |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Unstandardised |
Standardised coefficient β | P-value | Unstandardised |
Standardised coefficient β | P-value | Unstandardised |
Standardised coefficient β | P-value | Adjusted R2 | |||||
B | S.E. | B | S.E. | B | S.E. | |||||||||
Total | Pain: NRS | 3.24 | 0.22 | 0.65 | 0.000* | 2.93 | 0.23 | 0.58 | 0.000* | 1.78 | 0.24 | 0.36 | 0.000* | 0.6 |
COMDQ-15 | Treatment: TCS & other TTx | 17.37 | 2.14 | 0.58 | 0.000* | 15.95 | 2.04 | 0.53 | 0.000* | 7.2 | 1.72 | 0.24 | 0.000* | |
Treatment: TCS | 12.39 | 1.83 | 0.49 | 0.000* | 12.29 | 1.76 | 0.49 | 0.000* | 5.98 | 1.44 | 0.24 | 0.000* | ||
Stress: PSS-10 | 0.86 | 0.08 | 0.53 | 0.000* | 0.76 | 0.08 | 0.47 | 0.000* | 0.35 | 0.09 | 0.22 | 0.000* | ||
OLP activity: ODSS-activity | 0.75 | 0.11 | 0.38 | 0.000* | 0.68 | 0.1 | 0.34 | 0.000* | 0.26 | 0.1 | 0.13 | 0.009 | ||
Ethnicity: Asian | 8.6 | 1.56 | 0.31 | 0.000* | 8.31 | 1.72 | 0.3 | 0.000* | 2.8 | 1.21 | 0.1 | 0.021 | ||
Extraoral LP: skin LP | 6.46 | 2.12 | 0.17 | 0.002* | 6.06 | 2.01 | 0.16 | 0.003 | 3.19 | 1.45 | 0.09 | 0.028 | ||
Treatment: systemic treatment | 15.07 | 3.89 | 0.22 | 0.000* | 14.67 | 3.72 | 0.21 | 0.000* | 6.19 | 2.9 | 0.09 | 0.034 | ||
Physical | Pain: NRS | 1.32 | 0.09 | 0.65 | 0.000* | 1.29 | 0.09 | 0.64 | 0.000* | 0.84 | 0.11 | 0.42 | 0.000* | 0.53 |
discomfort | Treatment: TCS & other TTx | 7.74 | 0.84 | 0.64 | 0.000* | 7.29 | 0.84 | 0.6 | 0.000* | 3.67 | 0.75 | 0.3 | 0.000* | |
Treatment: TCS | 5.31 | 0.72 | 0.52 | 0.000* | 5.25 | 0.73 | 0.52 | 0.000* | 2.66 | 0.63 | 0.26 | 0.000* | ||
Stress: PSS-10 | 0.27 | 0.03 | 0.41 | 0.000* | 0.25 | 0.04 | 0.38 | 0.000* | 0.11 | 0.04 | 0.16 | 0.006 | ||
OLP activity: ODSS-activity | 0.33 | 0.04 | 0.41 | 0.000* | 0.31 | 0.04 | 0.38 | 0.000* | 0.12 | 0.04 | 0.15 | 0.007 | ||
At least 2 disease co-morbidities | 2.47 | 0.78 | 0.24 | 0.002* | 2.62 | 0.83 | 0.26 | 0.002* | 1.26 | 0.57 | 0.12 | 0.028 | ||
Medication Sc | Pain: NRS | 0.63 | 0.06 | 0.5 | 0.000* | 0.54 | 0.07 | 0.42 | 0.000* | 0.33 | 0.08 | 0.26 | 0.000* | 0.36 |
treatment | Treatment: TCS | 2.88 | 0.48 | 0.45 | 0.000* | 2.89 | 0.47 | 0.45 | 0.000* | 1.59 | 0.46 | 0.25 | 0.001* | |
Treatment: TCS & other TTx | 3.38 | 0.56 | 0.44 | 0.000* | 3.06 | 0.54 | 0.4 | 0.000* | 1.33 | 0.55 | 0.18 | 0.015 | ||
Ethnicity: Asian | 2.26 | 0.4 | 0.32 | 0.000* | 2.09 | 0.44 | 0.29 | 0.000* | 1.18 | 0.38 | 0.17 | 0.002* | ||
Treatment: systemic treatment | 3.6 | 1.03 | 0.21 | 0.001* | 3.51 | 0.99 | 0.2 | 0.000* | 1.79 | 0.92 | 0.1 | 0.05 | ||
Social & | Pain: NRS | 1.11 | 0.1 | 0.53 | 0.000* | 0.94 | 0.1 | 0.45 | 0.000* | 0.53 | 0.11 | 0.25 | 0.000* | 0.5 |
emotional | Anxiety: HADS-A | 0.65 | 0.06 | 0.55 | 0.000* | 0.57 | 0.06 | 0.48 | 0.000* | 0.27 | 0.07 | 0.22 | 0.000* | |
Stress: PSS-10 | 0.37 | 0.03 | 0.55 | 0.000* | 0.32 | 0.03 | 0.48 | 0.000* | 0.13 | 0.04 | 0.2 | 0.001* | ||
Treatment: TCS & other TTx | 5.47 | 0.93 | 0.44 | 0.000* | 4.84 | 0.89 | 0.39 | 0.000* | 2.12 | 0.79 | 0.17 | 0.008 | ||
Ethnicity: Asian | 3.91 | 0.64 | 0.34 | 0.000* | 3.62 | 0.71 | 0.31 | 0.000* | 1.71 | 0.54 | 0.15 | 0.002* | ||
Treatment: TCS | 3.48 | 0.8 | 0.33 | 0.000* | 3.44 | 0.76 | 0.33 | 0.000* | 1.48 | 0.66 | 0.14 | 0.025 | ||
Patient | Stress: PSS-10 | 0.07 | 0.02 | 0.26 | 0.000* | 0.07 | 0.02 | 0.24 | 0.000* | 0.06 | 0.02 | 0.2 | 0.016 | 0.08 |
support | Older age | −0.03 | 0.01 | −0.15 | 0.01 | −0.03 | 0.01 | −0.16 | 0.012 | −0.03 | 0.01 | −0.14 | 0.018 |
Bold value = P-value < 0.05.
Italic variables are significant variables at multivariale model.
TCS, topical corticosteroids; TTx, topical treatment.
Only independent variables with P-value less than 0.05 in multivariate model are displayed in the table.
Adjusted for age, sex, ethnicity, smoking, alcohol consumption and number of disease co-morbidities.
Statistical significance at Bonferroni-corrected P-value < 0.003.